BioMarin Pharma (BMRN) Misses Q2 EPS by 5c, Revenue Beats

Go back to BioMarin Pharma (BMRN) Misses Q2 EPS by 5c, Revenue Beats
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 64.18 +0.24 (0.38%)
Previous Close $63.94    52 Week High $108.96 
Open $64.35    52 Week Low $62.12 
Day High $64.96    P/E N/A 
Day Low $63.58    EPS $-1.27 
Volume 750,597